Steadfast Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Steadfast Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-92,981	Closed	-$53.9M	–	115
2025 Q4	$53.9M	Buy	92,981 +4,881	+6%	+$2.76M	0.93%	37
2025 Q3	$42.7M	Buy	+88,100	New	+$41M	0.75%	39
2024 Q2	–	Sell	-55,300	Closed	-$32.1M	–	70
2024 Q1	$32.1M	Sell	55,300 -78,100	-59%	-$43.8M	0.72%	36
2023 Q4	$70.8M	Buy	+133,400	New	+$64.6M	1.75%	29

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Steadfast Capital Management's TMO Position: Q1 2026 in Review

Steadfast Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 92,981 shares — an estimated $53.9M sold.

Steadfast Capital Management first reported a position in TMO in Q4 2023 and held it in 4 quarters. The position peaked at $70.8M in Q4 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Steadfast Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Steadfast Capital Management sold 92,981 Thermo Fisher Scientific shares in Q1 2026, an estimated $53.9M.
Steadfast Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 4 quarters.
Steadfast Capital Management's Thermo Fisher Scientific position peaked at $70.8M in Q4 2023.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Steadfast Capital Management's 13F filing for Q1 2026, filed 15 May 2026.